From: Autoimmune uveitis: a retrospective analysis of 104 patients from a tertiary reference center
Treatment | Remission | Improvement | Worsening | ||||||
---|---|---|---|---|---|---|---|---|---|
( n , %) | (45 pts, 43.3%) | (28 pts, 26.9%) | (31 pts, 29.8%) | ||||||
Anterior | Intermediate | Posterior | Panuveitis | Anterior | Intermediate | Posterior | Panuveitis | ||
Corticosteroids (5, 4.8) | 2 | 1 | 1 | 1 | |||||
Corticosteroids + Azathioprine (36, 34.6) | 9 | 1 | 7 | 1 | 2 | 1 | 15 | ||
Corticosteroids + Cyclosporin-A (35, 34.6) | 1 | 1 | 8 | 2 | 1 | 8 | 1 | 12 | |
Corticosteroids + Cyclophosphamide (8, 7.6) | 3 | 1 | 1 | 1 | 2 | ||||
Corticosteroids + Methotrexate (2, 1.9) | 1 | 1 | 1 | ||||||
Corticosteroids + combined immuno-suppressive therapy (8, 7.6) | 1 | 1 | 2 | 2 | 1 | 1 | |||
Anti-tumor necrosis factor-α (7, 6.7) | 1 | 3 | 3 | 0 | |||||
Anti-vascular endothe-lial growth factor (3, 2.9) | 2 | 1 | 0 |